Abstract
An estimated three to seven million Americans suffer from obsessive compulsive disorder at some time in their lives. Until recently, obsessive compulsive disorder was considered refractory to most treatments. However, recent studies indicate a better prognosis with behavioral therapy, antidepressant medications, or both. Behavioral treatment is generally more effective for compulsions than for obsessions.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ananth J., Pecknold J. C., van den Steen N., Engelsmann F. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog Neuropsychopharmacol. 1981;5(3):257–262. doi: 10.1016/0364-7722(81)90077-1. [DOI] [PubMed] [Google Scholar]
- Ananth J., Solyom L., Bryntwick S., Krishnappa U. Chlorimipramine therapy for obsessive-compulsive neurosis. Am J Psychiatry. 1979 May;136(5):700–701. doi: 10.1176/ajp.136.5.700. [DOI] [PubMed] [Google Scholar]
- Ananth J. Treatment of obsessive compulsive neurosis: pharmacological approach. Psychosomatics. 1976;17(4):180–184. doi: 10.1016/S0033-3182(76)71110-1. [DOI] [PubMed] [Google Scholar]
- Foa E. B., Steketee G., Turner R. M., Fischer S. C. Effects of imaginal exposure to feared disasters in obsessive-compulsive checkers. Behav Res Ther. 1980;18(5):449–455. doi: 10.1016/0005-7967(80)90010-8. [DOI] [PubMed] [Google Scholar]
- Insel T. R., Murphy D. L. The psychopharmacological treatment of obsessive-compulsive disorder: a review. J Clin Psychopharmacol. 1981 Sep;1(5):304–311. doi: 10.1097/00004714-198109000-00006. [DOI] [PubMed] [Google Scholar]
- Pauls D. L., Towbin K. E., Leckman J. F., Zahner G. E., Cohen D. J. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry. 1986 Dec;43(12):1180–1182. doi: 10.1001/archpsyc.1986.01800120066013. [DOI] [PubMed] [Google Scholar]
- Rachman S., Marks I. M., Hodgson R. The treatment of obsessive-compulsive neurotics by modelling and flooding in vivo. Behav Res Ther. 1973 Nov;11(4):463–471. doi: 10.1016/0005-7967(73)90105-8. [DOI] [PubMed] [Google Scholar]
- Rasmussen S. A. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder. Am J Psychiatry. 1984 Oct;141(10):1283–1285. doi: 10.1176/ajp.141.10.1283. [DOI] [PubMed] [Google Scholar]
- Rasmussen S. A., Tsuang M. T. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry. 1986 Mar;143(3):317–322. doi: 10.1176/ajp.143.3.317. [DOI] [PubMed] [Google Scholar]
- Robins L. N., Helzer J. E., Weissman M. M., Orvaschel H., Gruenberg E., Burke J. D., Jr, Regier D. A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984 Oct;41(10):949–958. doi: 10.1001/archpsyc.1984.01790210031005. [DOI] [PubMed] [Google Scholar]
- Thorén P., Asberg M., Cronholm B., Jörnestedt L., Träskman L. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Arch Gen Psychiatry. 1980 Nov;37(11):1281–1285. doi: 10.1001/archpsyc.1980.01780240079009. [DOI] [PubMed] [Google Scholar]
- Tippin J., Henn F. A. Modified leukotomy in the treatment of intractable obessional neurosis. Am J Psychiatry. 1982 Dec;139(12):1601–1603. doi: 10.1176/ajp.139.12.1601. [DOI] [PubMed] [Google Scholar]
- Zohar J., Insel T. R. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry. 1987 Jun;22(6):667–687. doi: 10.1016/0006-3223(87)90199-5. [DOI] [PubMed] [Google Scholar]